Clinical Trials Browser

Phase 3 × Cognitive Dysfunction × CNS × Clear all

NCT05230758 2026-01-22

Met Med Can

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

NCT02360215 2025-04-23

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Phase 3 Completed

518 enrolled 40 charts

Brain Neoplasms, Cognitive Dysfunction

NCT04395339 2024-08-01

GLORY

Phase 3 Terminated

Brain Neoplasms, Breast Neoplasms, Gangliosidoses, Radiation Injuries, Gangliosidosis, GM1, Cognitive Dysfunction